Uncomplicating the futureSM
 
Search

Healthcare Professionals

    Print page  

Submit Medical Questions

Genzyme Corporation ("Genzyme") respects individual privacy and values the confidence of its customers, partners, patients and employees. This Privacy Policy and Notice of Information Practices sets forth Genzyme's practices regarding the collection, use and disclosure of information that you may provide through this site. Whenever you submit information through this site to Genzyme, you agree with the terms of Genzyme's Privacy Policy and Notice of Information Practices. Please review the privacy policy before submitting information through this website. By selecting "continue" you are agreeing to the terms of Genzyme's privacy policy.


Select "go back" to return to Genzyme's website.


 

Surgeons discuss
adhesions and their potential impact on patients
Aimee's Story
See what patients say about SEPRAFILM
 

Indication

Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

Important Safety Information

Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

Please see full prescribing information.

Terms and Conditions of Use | Privacy Policy | Contact Us | This site is intended for United States residents only © 2002-2010 Genzyme Corporation. All rights reserved. Seprafilm and Genzyme are registered trademarks of Genzyme Corporation. genzyme logo